Bile acid modulators in discovery: Identifying cholestasis candidates with the best chance of success
Unmet needs are high in cholestatic liver disease, where bile acid modulators show real potential. With smart DMPK strategies, cross-domain collaboration, and strong CDMO support, companies are pushing past the challenges of discovery biology.
